A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese (CRC)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01289288|
Recruitment Status : Completed
First Posted : February 3, 2011
Last Update Posted : May 21, 2013
The objective of this study is to test whether a culturally-tailored in-office based intervention have impact on increasing Chinese physician's recommendation of colorectal cancer (CRC) screening to their nonadherent Chinese patients.
Special aims are to:
- Evaluate the efficacy of a culturally-tailored physician intervention on increasing non-adherent Chinese American's patients' CRC screening rate.
- Identify factors that mediate or moderate the intervention effects. For example, patients who hold an eastern cultural view or are less acculturated will be more likely to benefit from the intervention than patients who hold a western view or who are more acculturated.
|Condition or disease||Intervention/treatment||Phase|
|Colorectal Cancer||Behavioral: Mailed printed materials and in-office training||Phase 1 Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||480 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese|
|Study Start Date :||July 2007|
|Primary Completion Date :||July 2012|
|Study Completion Date :||July 2012|
|Experimental: Mailed printed materials and in-office training||
Behavioral: Mailed printed materials and in-office training
No Intervention: Control
- Receipt of CRC screening [ Time Frame: 12 months ]Nonadherent Chinese American patient's CRC screening rates.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01289288
|United States, District of Columbia|
|Washington DC, District of Columbia, United States, 20007|
|United States, Pennsylvania|
|Philadelphia, Pennsylvania, United States, 19122|
|Principal Investigator:||Judy Wang, Ph.D.||Georgetown University|